The above data imply that miR-128 may play a significant function in NSCLC carcinogenesis, partly through modulating revascularization and lymphangiogenesis via addressing VEGF-C and concurrently impeding AKT, p38, and the ERK signal transduction pathways. This evidence concerns the gene MAPK14 and non-small cell lung carcinoma.